Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 24, 2023
Dr. Phil Greenberg becomes president-elect of American Association for Cancer Research
Immunologist looks ahead to international leadership role
The New Yorker spotlights Fred Hutch’s pioneering cancer research
‘The Promise and Price of Cellular Therapies’ by Siddhartha Mukherjee traces journey from bone marrow transplantation to immunotherapy
Dr. Tijana Martinov named a 2019 Parker Scholar
Early-career scientist will use funding for immunotherapy research in multiple myeloma
5 questions with a cancer immunotherapy expert
Dr. Phil Greenberg to receive high honor for his contributions to the field
Tinkering with T cells
How researchers are tweaking engineered immune cells’ cancer-targeting receptors — and why it matters
Fred Hutch metastatic breast cancer researchers awarded nearly $500K
Celebrating faculty and staff achievements
Good News: Fred Hutch immunotherapy expert Dr. Phil Greenberg joins Parker Institute
Celebrating faculty and staff achievements
Promising results in trial of engineered T cells in high-risk leukemia
High response rates to experimental immunotherapy in patients with treatment-resistant chronic lymphocytic leukemia
A Pathway to Independence Award for Dr. Amit Sharma
Celebrating faculty and staff achievements
New clues to treating deadly skin cancer
Small clinical trial finds two forms of immunotherapy may be better than one for treating metastatic melanoma
Tailoring immune cells to target leukemia
Promising early trial results show engineered immune cells may help buffer against cancer relapse after bone marrow transplantation
Good News at Fred Hutch
Celebrating faculty and staff achievements